Clinical Features, Gene Alterations, and Outcomes in Prefibrotic and Overt Primary and Secondary Myelofibrotic Patients

Clinical Features, Gene Alterations, and Outcomes in Prefibrotic and Overt Primary and Secondary Myelofibrotic Patients

The Philadelphia-negative myeloproliferative neoplasms (MPNs) are divided in three major groups: polycythemia vera (PV), essential thrombocythemia (ET), and primary myelofibrosis (PMF). The 2016 WHO classification incorporates also prefibrotic PMF (pre-PMF) and overt PMF. This study aimed to discrim...

Full description

Bibliographic Details
Main Authors: Tong-Yoon Kim, Daehun Kwag, Jong-Hyuk Lee, Joonyeop Lee, Gi-June Min, Sung-Soo Park, Silvia Park, Young-Woo Jeon, Jae-Ho Yoon, Seung-Hawn Shin, Seung-Ah Yahng, Byung-Sik Cho, Ki-Seong Eom, Yoo-Jin Kim, Seok Lee, Hee-Je Kim, Chang-Ki Min, Seok-Goo Cho, Jong-Wook Lee, Jong-Mi Lee, Myungshin Kim, Sung-Eun Lee
Format: Article
Language:English
Published: MDPI AG 2022-09-01
Series:Cancers
Subjects:
genetic alteration
prefibrotic primary myelofibrosis
overt primary myelofibrosis
secondary myelofibrosis
Online Access:https://www.mdpi.com/2072-6694/14/18/4485

Internet

https://www.mdpi.com/2072-6694/14/18/4485

Similar Items